Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Keytruda (pembrolizumab) - Merck (MSD)
https://app.dgt26mz.smart-abstract.com/sm-events/day/event/120469/123821
M. Ried1; V. Gruner1; J. Riedel1; T. Robold2; H.-S. Hofmann1, 2
Sep 9, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next